Portfolio company
BioFactor Therapeutics AB
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This pharmaceutical developer creates recombinant protein therapies for patients with metabolic and endocrine disorders.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
BioCrine AB
This company develops diabetes treatments and in-vivo imaging technology for pharmaceutical and biotechnology partners and academic researchers.
ProFactor Pharma
This company develops recombinant Factor VIII to treat haemophilia A in patients who currently lack access to affordable medication.
35Pharma
This biopharmaceutical company develops protein-based therapeutics for patients suffering from pulmonary hypertension, heart failure, cardiometabolic disease and obesity.
AdipoPharma
This clinical-stage biotechnology company develops therapeutic peptides to treat insulin resistance and type 2 diabetes for patients with metabolic disorders.
Protuoso Biosciences
This company develops multifunctional recombinant fusion proteins for pharmaceutical researchers and clinicians treating cardiometabolic, oncological and autoimmune diseases.
Melacure Therapeutics AB
This biotechnology company develops small molecule drugs targeting melanocortin receptors to treat metabolic, inflammatory and skin disorders for the pharmaceutical industry.
OxThera AB
This biopharmaceutical company develops bacteria-based therapies to treat patients with primary hyperoxaluria and other rare kidney diseases.
Zealand Pharma
This biotechnology company develops peptide-based medicines for patients with obesity, rare diseases and chronic inflammation through metabolic health research.